Press Release Details
Colfax Reports Fourth Quarter and Full Year 2011 Results
Fourth Quarter of 2011 (all comparisons versus the fourth quarter of 2010)
- After
$25.3 million of pre-tax expense related to the Charter acquisition, a net loss of$16.1 million (37 cents per share); adjusted net income (as defined below) of$17.6 million (40 cents per share), an increase of 4.1% - Net sales of
$177.8 million , an increase of 6.7% - Operating loss of
$7.6 million ; adjusted operating income (as defined below) of$26.8 million , an increase of 1.1% - Fourth quarter orders of
$153.4 million , an increase of 14.8%; organic order increase (as defined below) of 8.8% - Backlog of
$347.2 million at period end
Full Year 2011 (all comparisons versus full year 2010)
- Net income of
$4.6 million (10 cents per share — basic and diluted); adjusted net income (as defined below) of$58.1 million ($1.31 per share), an increase of 44.5% - Net sales of
$693.4 million , an increase of 27.9%; organic sales increase (as defined below) of 9.0% - Operating income of
$25.9 million ; adjusted operating income (as defined below) of$89.6 million , an increase of 36.2% - Orders for the year 2011 of
$682.8 million , an increase of 28.2%; organic order increase (as defined below) of 12.2%
Adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth (decline) and organic order growth are not financial measures calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP"). See below for a description of the measures' usefulness and a reconciliation of these measures to their most directly comparable GAAP financial measures.
"We made significant progress on our strategic priorities during 2011 and have reduced our cost base in fluid handling as we enter 2012. We also announced the closing of the acquisition of Charter International plc on
Non-GAAP Financial Measures and Other Adjustments
Colfax has provided in this press release financial information that has not been prepared in accordance with GAAP. These non-GAAP financial measures are adjusted net income, adjusted net income per share, adjusted operating income, earnings before interest, taxes and depreciation (EBITDA), adjusted EBITDA, organic sales growth (decline) and organic order growth. Adjusted net income, adjusted net income per share, adjusted EBITDA and adjusted operating income exclude asbestos liability and defense costs and asbestos coverage litigation expenses, restructuring and other related charges, and beginning in Q3 2011, charges related to the Charter acquisition to the extent they impact the periods presented. The effective tax rates used to calculate adjusted net income, adjusted net income per share and projected adjusted net income per share are 30.5% for the full year and Q4 periods of 2011 in comparison to 32% for both the full year and Q4 periods of 2010. Organic sales growth and organic order growth exclude the impact of acquisitions and foreign exchange rate fluctuations. These non-GAAP financial measures assist Colfax in comparing its operating performance on a consistent basis because, among other things, they remove the impact of legacy asbestos issues, costs related to the Charter acquisition and items outside the control of its operating management team.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.
Conference Call and Webcast
Colfax will host a conference call to provide details about its results on
About
CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current fact, including projections of future financial results, the expected effects of the Charter acquisition, its anticipated benefits and potential impact on our business and our ability to realize cost savings. Forward-looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax's results to differ materially from current
expectations include, but are not limited to factors detailed in Colfax's reports filed with the
The term "Colfax" in reference to the activities described in this press release may mean one or more of Colfax's global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by
Condensed Consolidated Statements of Operations Dollars in thousands, except per share data (Unaudited) | |||||
Three Months Ended | Year Ended December 31, | ||||
2011 | 2010 | 2011 | 2010 | ||
Net sales | $ 177,791 | $ 166,651 | $ 693,392 | $ 541,987 | |
Cost of sales | 116,247 | 107,077 | 453,293 | 350,579 | |
Gross profit | 61,544 | 59,574 | 240,099 | 191,408 | |
Selling, general and administrative expense | 33,625 | 31,597 | 144,817 | 119,426 | |
Research and development expense | 1,167 | 1,474 | 5,707 | 6,205 | |
Charter acquisition-related expense(1) | 25,324 | — | 31,052 | — | |
Restructuring and other related charges | 2,162 | 808 | 9,680 | 10,323 | |
Asbestos liability and defense cost | 4,593 | 3,697 | 12,237 | 7,876 | |
Asbestos coverage litigation expense | 2,246 | 2,443 | 10,700 | 13,206 | |
Operating (loss) income | (7,573) | 19,555 | 25,906 | 34,372 | |
Interest expense | 1,412 | 1,609 | 5,919 | 6,684 | |
(Loss) income before income taxes | (8,985) | 17,946 | 19,987 | 27,688 | |
Provision for income taxes(2) | 7,095 | 9,296 | 15,432 | 11,473 | |
Net (loss) income | $ 8,650 | $ 4,555 | |||
Net (loss) income per share—basic and diluted | $ (0.37) | $ 0.20 | $ 0.10 | $ 0.37 | |
_________ (1) Includes (2) Income tax provision is significantly higher than the statutory rates primarily due to the increased valuation allowance recorded against loss carryforwards in | |||||
Selected Balance Sheet and Cash Flow Metrics Dollars in thousands (Unaudited) | |||
2011 | 2010 | ||
Trade receivables, net | $ 117,475 | $ 98,070 | |
Inventories, net | 56,136 | 57,941 | |
Accounts payable | (54,035) | (50,896) | |
Working capital | $ 119,576 | $ 105,115 | |
Total debt | $ 111,518 | $ 82,500 | |
Year Ended December 31 | |||
2011 | 2010 | ||
Depreciation, amortization and fixed asset impairment charges | $ 22,598 | $ 16,130 | |
Purchase of fixed assets | (14,786) | (12,527) | |
Restructuring cash outflows | (6,812) | (16,300) | |
Payments of Charter acquisition-related expenses | (3,501) | — | |
Reconciliation of GAAP to Non-GAAP Financial Measures Dollars in thousands, except per share data (Unaudited) | |||||
Three Months Ended | Year Ended December 31, | ||||
2011 | 2010 | 2011 | 2010 | ||
EBITDA | |||||
Net (loss) income | $ (16,080) | $ 8,650 | $ 4,555 | $ 16,215 | |
Interest expense | 1,412 | 1,609 | 5,919 | 6,684 | |
Provision for income taxes | 7,095 | 9,296 | 15,432 | 11,473 | |
Depreciation and amortization | 5,172 | 4,888 | 22,598 | 16,130 | |
EBITDA | $ (2,401) | $ 24,443 | $ 48,504 | $ 50,502 | |
EBITDA margin | n/m(1) | 14.7% | 7.0% | 9.3% | |
Adjusted EBITDA | |||||
Net (loss) income | $ (16,080) | $ 8,650 | $ 4,555 | $ 16,215 | |
Interest expense | 1,412 | 1,609 | 5,919 | 6,684 | |
Provision for income taxes | 7,095 | 9,296 | 15,432 | 11,473 | |
Depreciation and amortization | 5,172 | 4,888 | 22,598 | 16,130 | |
Charter acquisition-related expense | 25,324 | — | 31,052 | — | |
Restructuring and other related charges | 2,162 | 808 | 9,680 | 10,323 | |
Asbestos liability and defense cost | 4,593 | 3,697 | 12,237 | 7,876 | |
Asbestos coverage litigation expense | 2,246 | 2,443 | 10,700 | 13,206 | |
Adjusted EBITDA | $ 31,924 | $ 31,391 | $ 112,173 | $ 81,907 | |
Adjusted EBITDA margin | 18.0% | 18.8% | 16.2% | 15.1% | |
Adjusted Operating Income | |||||
Operating (loss) income | $ (7,573) | $ 19,555 | $ 25,906 | $ 34,372 | |
Charter acquisition-related expense | 25,324 | — | 31,052 | — | |
Restructuring and other related charges | 2,162 | 808 | 9,680 | 10,323 | |
Asbestos liability and defense cost | 4,593 | 3,697 | 12,237 | 7,876 | |
Asbestos coverage litigation expense | 2,246 | 2,443 | 10,700 | 13,206 | |
Adjusted operating income | $ 26,752 | $ 26,503 | $ 89,575 | $ 65,777 | |
Adjusted operating income margin | 15.0% | 15.9% | 12.9% | 12.1% | |
Adjusted Net Income and Adjusted Earnings Per Share | |||||
Net (loss) income | $ (16,080) | $ 8,650 | $ 4,555 | $ 16,215 | |
Charter acquisition-related expense | 25,324 | — | 31,052 | — | |
Restructuring and other related charges | 2,162 | 808 | 9,680 | 10,323 | |
Asbestos liability and defense cost | 4,593 | 3,697 | 12,237 | 7,876 | |
Asbestos coverage litigation expense | 2,246 | 2,443 | 10,700 | 13,206 | |
Tax adjustment to effective rate(2) | (634) | 1,330 | (10,083) | (7,437) | |
Adjusted net income | $ 17,611 | $ 16,928 | $ 58,141 | $ 40,183 | |
Adjusted net income margin | 9.9% | 10.2% | 8.4% | 7.4% | |
Weighted-average shares outstanding—diluted | 44,279,400 | 43,876,791 | 44,268,110 | 43,667,225 | |
Adjusted net income per share | $ 0.40 | $ 0.39 | $ 1.31 | $ 0.92 | |
Net (loss) income per share—diluted (in accordance with GAAP) | $ (0.37) | $ 0.20 | $ 0.10 | $ 0.37 | |
_________ (1) Measure is not meaningful. (2) The effective tax rates used to calculate adjusted net income and adjusted net income per share present income taxes are 30.5% for the full year and Q4 periods of 2011 in comparison to 32% for the full year and Q4 periods of 2010. | |||||
Change in Sales, Orders and Backlog Dollars in millions (Unaudited) | ||||||
Net Sales | Orders | |||||
$ | % | $ | % | |||
(In millions) | ||||||
Three months ended | $ 166.7 | $ 133.6 | ||||
Components of Change: | ||||||
Existing businesses | (3.8) | (2.3)% | 11.8 | 8.8 % | ||
Acquisitions | 15.6 | 9.4 % | 8.9 | 6.7 % | ||
Foreign currency translation | (0.7) | (0.4)% | (0.9) | (0.7)% | ||
11.1 | 6.7 % | 19.8 | 14.8 % | |||
Three months ended | $ 177.8 | |||||
Net Sales | Orders | Backlog at Period End | |||||||
$ | % | $ | % | $ | % | ||||
(In millions) | |||||||||
As of and for the year ended | $ 542.0 | $ 313.5 | |||||||
Components of Change: | |||||||||
Existing businesses | 48.8 | 9.0 % | 65.0 | 12.2 % | (1.1) | (0.4)% | |||
Acquisitions | 81.3 | 15.0 % | 64.0 | 12.0 % | 40.2 | 12.8 % | |||
Foreign currency translation | 21.3 | 3.9 % | 21.0 | 4.0 % | (5.4) | (1.7 %) | |||
151.4 | 27.9 % | 150.0 | 28.2 % | 33.7 | 10.7 % | ||||
As of and for the year ended | $ 693.4 | $ 347.2 | |||||||
SOURCE
News Provided by Acquire Media